| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sab Biotherapeutics, Inc. (SABS) has 15 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. SABS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.80M | $18.24M | - | |
| Pres | 3.00M | $11.40M | - | |
| Dir | 2.20M | $8.35M | - | |
| Other | 1.20M | $4.56M | - | |
| COO | 600.0K | $2.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Sullivan Eddie Joe | Chief Executive Officer | Buy | 1,740 | $0.88 | $1,531.20 | - | -40.4% | -65.4% | |
| Nov 30, 2023 | King Michael | Chief Financial Officer | Buy | 5,000 | $0.90 | $4,500.00 | New | -56.6% | -70.0% | |
| Nov 29, 2023 | Reich Samuel J | Executive Chairman | Buy | 11,000 | $0.89 | $9,841.70 | +5.3% | -42.5% | -66.4% | |
| Sep 13, 2022 | Hamilton Christine E | Director, 10% Owner | Buy | 10,000 | $0.73 | $7,297.00 | +0.2% | +35.2% | -15.3% | |
| Sep 7, 2022 | Sullivan Eddie Joe | Chief Executive Officer | Buy | 14,000 | $0.74 | $10,315.20 | +0.3% | +54.2% | +1.3% | |
| Oct 26, 2021 | Beyer Russell P | Chief Financial Officer | Sell | 278 | $7.90 | $2,196.20 | -100% | -37.7% | -91.9% | |
| Oct 14, 2021 | Reich Samuel J | CEO And CFO | Buy | 1,000 | $10.11 | $10,110.00 | New | -25.1% | -92.1% | |
| Oct 13, 2021 | Katz Ilan | - | Buy | 500 | $10.11 | $5,052.50 | +50.0% | -24.1% | -92.4% | |
| Oct 1, 2021 | Katz Ilan | Director, 10% Owner | Buy | 1,000 | $10.09 | $10,090.00 | New | -21.0% | -93.0% | |
| Oct 1, 2021 | Spragens Jeffrey G | Director | Buy | 13,000 | $10.07 | $130,910.00 | New | -21.0% | -93.0% |